A
Allogene Therapeutics
South San Francisco, United States
Founded 2018 NASDAQ: ALLO
Cell Therapy Nano Gene Therapy Delivery Nanomedicine Nano-Bio Regenerative Medicine Protein Nanoparticles
About
Clinical-stage biotechnology company pioneering allogeneic CAR T cell therapies
Company Details
- Type
- public
- Employees
- 400+
- Funding
- Public
Key Products
- ALLO-501A
- ALLO-316
- ALLO-605